Journal profile · Biochemistry & Molecular Biology
Acta Biochimica Polonica
ISSN 0001-527X · eISSN 1734-154X · Acta Biochimica Polonica · POLAND · Quarterly
Acta Biochimica Polonica: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 2.23; fully open access; APC about USD 1,750; median 83 days to acceptance (63 articles, last 24 months); community-reported acceptance: easy; 25 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Acta Biochimica Polonica is published by Acta Biochimica Polonica and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are RNA and protein synthesis mechanisms, Glycosylation and Glycoproteins Research and Mitochondrial Function and Pathology, together about 21.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Acta Biochimica Polonica (ABP) is a multidisciplinary Open Access journal that publishes premier research in the field of biochemistry. ABP is the official journal of the Polish Biochemical Society (Polskie Towarzystwo Biochemiczne). Led by Prof. Grzegorz Węgrzyn from the University of Gdansk, ABP welcomes research contributions in the various domains of biochemistry, which bridge the gap between scientific discovery and clinical application. Areas of interest include, but are not limited to: Enzymology and metabolism Membranes and bioenergetics Gene structure and expression Protein, nucleic acid, and carbohydrate structure and metabolism ABP is committed to advancing developments in the field of biochemistry by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future. The journal welcomes submissions that support and advance the following Sustainable Development Goals (SDGs): SDG 3: Good Health and Well-being - Contributions to medical sciences for better health outcomes and disease treatments. SDG 9: Industry, Innovation, and Infrastructure - Promoting innovation in biochemical fields and related industries. SDG 4: Quality Education - Providing educational resources globally, enhancing education in biochemistry.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief Reviewer ClearPublisher website
Editorial board by country: 2 in mainland China (about 18%); most named Poland 5, Mainland China 2, United States 1, United Kingdom 1, India 1 (11 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology9.1%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology6.5%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology6.3%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5.2%
- Bacterial Genetics and BiotechnologyBiochemistry, Genetics and Molecular Biology4.7%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology4.7%
- Enzyme Structure and FunctionMaterials Science4.4%
- DNA and Nucleic Acid ChemistryBiochemistry, Genetics and Molecular Biology4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCCASPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.23LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 4.8LetPub ·
- CiteScore (publisher)
- 4.8Publisher website ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.51LetPub ·
- h-index
- 72LetPub ·
- h-index
- 106OpenAlex ·
- i10-index
- 1,597OpenAlex ·
- 2-year mean citedness
- 4.83OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 98.25%LetPub ·
Volume
- Articles per year
- 24LetPub ·
Articles by year OpenAlex count · 3,856 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 33 | 33 | 10 |
| 2025 | 25 | 25 | 219 |
| 2024 | 23 | 23 | 162 |
| 2023 | 124 | 124 | 586 |
| 2022 | 116 | 116 | 644 |
| 2021 | 122 | 122 | 849 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
83 daysMedian, submission to acceptance · P25–P75 57 days – 119 days
- Acceptance to online
- median 15 days (63 articles)
- Submission to online
- median 105 days
- Sample
- 63 articles with submission and acceptance dates (64 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,750 | — | — | |
| LetPub | USD 1,750 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Keywords
- ≥ 5
Policy excerpts from the journal's websiteLicense & copyright, Open access, Peer review
- License & copyright 2.1. CC-BY Licence
Figures, tables, and images are published under a Creative Commons CC-BY licence; permission must be obtained for use of copyrighted material from other sources. Model summary
All figures, tables, and images will be published under a Creative Commons CC-BY licence, and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, follow any citation instructions requested by third-party rights holders, …
Source ↗Publisher website ·- Open access Open Access Statement
ABP provides online free gold open access to the journal and all of its research publications.Open Access funder and institutional mandates: ABP is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Coun…
Source ↗Publisher website ·- Peer review
The journal participates in CrossMark, a multi-publisher initiative to provide a standard way for readers to locate the current version of a piece of content and alert readers to changes. Model summary
CrossMark is a multi-publisher initiative to provide a standard way for readers to locate the current version of a piece of content. By applying the CrossMark logo the journal is committed to maintaining the content it publishes and to alerting readers to changes if and when they occur.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Acta Biochimica Polonica
- Country or region
- POLAND
- Language
- English
- Frequency
- Quarterly
- ISSN
- 0001-527X
- Electronic ISSN
- 1734-154X
- Society / sponsor
- Polskie Towarzystwo Biochemiczne
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Acta Biochimica Polonica
What CAS zone is Acta Biochimica Polonica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Biochimica Polonica is in Zone 4 of Biology, and in Zone 4 of the minor category Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 4 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Acta Biochimica Polonica?
The latest impact factor listed by LetPub is 2.23; CiteScore 4.8, h-index 106.
How long does peer review take at Acta Biochimica Polonica?
Based on the dates recorded on 63 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 57–119 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Acta Biochimica Polonica based?
Of the 11 board members whose country the journal's board page names, 2 (about 18%) are in mainland China; the countries named most often are Poland (5), Mainland China (2) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Acta Biochimica Polonica?
According to LetPub and DOAJ records, Acta Biochimica Polonica is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC and CAS; that list has not been checked against each database.
Is Acta Biochimica Polonica open access, and what is the APC?
Acta Biochimica Polonica is a fully open-access journal. APC about USD 1,750.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .